CAS 98769-84-7
:Reboxetine mesylate
Description:
Reboxetine mesylate is a pharmaceutical compound primarily used as an antidepressant, classified as a selective norepinephrine reuptake inhibitor (NRI). It is the mesylate salt form of reboxetine, which enhances its solubility and stability. The compound is characterized by its ability to increase norepinephrine levels in the synaptic cleft by inhibiting its reuptake into presynaptic neurons, thereby improving mood and alleviating symptoms of depression. Reboxetine mesylate is typically administered orally and is known for its relatively favorable side effect profile compared to other antidepressants. Its chemical structure includes a piperidine ring, contributing to its pharmacological activity. The substance is generally well-absorbed in the gastrointestinal tract, with a half-life that allows for once-daily dosing. As with any medication, it is essential to consider potential side effects, contraindications, and interactions with other drugs. Overall, reboxetine mesylate represents a significant option in the treatment of major depressive disorder, particularly for patients who may not respond well to traditional selective serotonin reuptake inhibitors (SSRIs).
Formula:C19H23NO3·CH4O3S
InChI:InChI=1/C19H23NO3.CH4O3S/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18;1-5(2,3)4/h3-11,18-20H,2,12-14H2,1H3;1H3,(H,2,3,4)/t18-,19-;/s2
InChI key:InChIKey=CGTZMJIMMUNLQD-QLJMZTSGNA-N
SMILES:[C@@H](OC1=C(OCC)C=CC=C1)(C2=CC=CC=C2)[C@]3(CNCCO3)[H].S(C)(=O)(=O)O
Synonyms:- (2S)-2-[(S)-(2-ethoxyphenoxy)(phenyl)methyl]morpholine methanesulfonate
- 2-[(2-Ethoxyphenoxy)phenylmethyl]morpholine mesylate
- Davedax
- Edronax
- Fce 20124
- Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-(±)-, methanesulfonate
- Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate
- Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-, methanesulfonate (1:1)
- Pnu 155905E
- Pnu 155950E
- Reboxetine mesilate
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 12 products.
Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-,methanesulfonate
CAS:Formula:C20H27NO6SPurity:%Color and Shape:SolidMolecular weight:409.4965Reboxetine mesylate
CAS:Formula:C19H23NO3·CH3SO3HPurity:≥ 97.0%Color and Shape:White to off-white powderMolecular weight:409.50Reboxetine Mesylate
CAS:Formula:C19H23NO3·CH4O3SColor and Shape:White To Off-White SolidMolecular weight:313.40 96.11Reboxetine Mesilate
CAS:Controlled ProductFormula:C19H23NO3·CH4O3SColor and Shape:NeatMolecular weight:409.50Reboxetine mesylate
CAS:<p>Reboxetine mesylate (FCE20124 mesylate) is a norepinephrine reuptake inhibitor (Ki: 8.2 nM).</p>Formula:C19H23NO3·CH4O3SPurity:99.18% - 99.87%Color and Shape:Tan Or Off-White Cyrstalline SolidMolecular weight:409.5Reboxetine Mesylate
CAS:Controlled Product<p>Applications A selective noradrenaline reuptake inhibitor. Antidepressant.<br>References Cocchiara, G., et al.: Eur. J. Drug. Metab. Pharmacokinet., 16, 231 (1991), Pelliazoni, C., et al.: Biopharm. Drug. Dispos., 17, 623 (1996),<br></p>Formula:C19H23NO3·CH4O3SColor and Shape:Off White SolidMolecular weight:409.50Reboxetine mesylate
CAS:Controlled Product<p>Reboxetine mesylate is a drug that belongs to the class of tricyclic antidepressants. It is a selective and potent inhibitor of neuronal reuptake of norepinephrine (noradrenaline). Reboxetine also interacts with neurokinin-1 receptor, which may affect locomotor activity and hippocampal formation, resulting in effects to memory and learning. It has been shown to be effective in the treatment of symptoms related to depression and Parkinson's disease.</p>Formula:C20H27NO6SPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:409.5 g/molReboxetine mesylate - Bio-X ™
CAS:Controlled Product<p>Reboxetine mesylate is a drug that belongs to the class of tricyclic antidepressants. It is a selective and potent inhibitor of neuronal reuptake of norepinephrine (noradrenaline). Reboxetine also interacts with neurokinin-1 receptors, which may affect locomotor activity and hippocampal formation, resulting in effects to memory and learning. It has been shown to be effective in the treatment of symptoms related to depression and Parkinson's disease.</p>Formula:C20H27NO6SPurity:Min. 98 Area-%Molecular weight:409.5 g/mol









